English

DNA Interactions and Cytotoxicity of Imidazole-Modified Naphthalimides

• GAO Yunyan ,
• CAI Wenjiao ,
• OU Zhize ^, ,
• MA Tuotuo ,
• YI Na ,
• LI Zhiyuan

• The Key Laboratory of Space Applied Physics and Chemistry, Ministry of Education, Department of Applied Chemistry, School of Science, Northwestern Polytechnical University, Xi'an 710072, P. R. China

Corresponding author: OU Zhize, Email: ouzhize@nwpu.edu.cn; Tel. & Fax: +86-29-88431677

• Received Date: 30 October 2017
  Accepted Date: 21 November 2017
  Revised Date: 21 November 2017
  Available Online: 15 February 2019
• Fund Project:

  The project was supported by the Natural Science Foundation of Shaanxi Province, China (2016JM2013), the National Natural Science Foundation of China (21073143), and the NPU Foundation for Graduate Innovation (Z2017208)

Abstract: The rational design of naphthalimide derivatives, which can target specific DNA sequences and secondary structural DNA, is important for developing potential anticancer drugs. In this work, the naphthalimide-imidazole conjugate (3) and its alkylated derivatives (4a–c) were synthesized, and characterized by ¹H NMR, ¹³C NMR, and mass spectrometry (MS). The interactions of these compounds with calf thymus DNA (CT DNA) and G-quadruplex DNA were investigated by UV-Vis spectroscopy, fluorescence spectroscopy, circular dichroism, and fluorescence resonance energy transfer (FRET). The studies revealed that the naphthalimides with imidazolium displayed higher affinity towards CT DNA than those with the imidazole moiety, suggesting that the electrostatic interaction plays an important role in the interactions between the naphthalimide and the DNA duplex. All of the obtained naphthalimide derivatives possessed high affinity (K_a > 4 × 10⁶ L·mol^-1) towards the telomeric G-quadruplex, and exhibited more than 30-fold selectivity for the quadruplex versus CT DNA. The viscosity of CT DNA increased upon addition of the naphthalimides, suggesting that the latter could bind to the former via a classical intercalation mode. FRET results indicated that the compounds 3 and 4a–c stabilized the structure of the telomeric G-quadruplex by increasing its melting temperature by 5.8, 10.7, 8.4, and 7.8 ℃, respectively. CD spectral results suggested that the telomeric G-quadruplex maintained a mixture of antiparallel and parallel conformation in the presence of the naphthalimide derivatives (3 and 4a–c) in a buffer containing K⁺. The fluorescence intensity of the naphthalimide derivatives 3 and 4a, b with octylimidazolium was significantly enhanced upon interaction with the G-quadruplex, which could be attributed to the immersion of naphthalimide moieties in the hydrophobic region of the G-quadruplex. However, the fluorescence of compound 4c with hexadecylimidazolium increased only slightly upon addition of the G-quadruplex. Molecular docking studies indicated that the naphthalimide derivatives were associated with the loop and groove of the human telomeric G-quadruplex via hydrophobic interactions. A hydrogen bond was formed between the imidazole group in compound 3 and the guanine residue DG16. The phosphate group from the G-quadruplex backbone pointed to the imidazolium moiety of 4a–c, suggesting that the electrostatic interactions also played an important role. Being fluorescent, the cellular localization of 3 and 4a–c could be conveniently tracked by fluorescence imaging. The results showed that compounds 4a–c, which contained the imidazolium moiety, were mainly localized in the nucleus after 4.0 h of incubation, while compound 3 with the imidazole moiety was partially localized in the nucleus. The enhancement of the nuclear localization of 4a–c may be attributed to the positive charge in 4a–c and their higher DNA affinity. Based on the MTT assay results, it was concluded that compounds 4a–c displayed much stronger cytotoxic activity against breast cancer cells than 3. Furthermore, compounds 4a and 4b selectively inhibited the A549 cells over normal human lung fibroblast MRC-5 cells, with high anticancer activity. These results indicated that the G-quadruplex binding affinity and anticancer activity of naphthalimide could be modulated by conjugation with the imidazole moiety.

Key words:
• Naphthalimide
•  /  G-quadruplex
•  /  Anticancer drug
•  /  Imidazolium
•  /  Cytotoxicity

• 1. [1]

     Banerjee, S.; Veale, E. B.; Phelan, C. M.; Murphy, S. A.; Tocci, G. M.; Gillespie, L. J.; Frimannsson, D. O.; Kelly J. M.; Gunnlaugsson, T. Chem. Soc. Rev. 2013, 42, 1601. doi: 10.1039/C2CS35467E

  2. [2]

     Ratain, M. J.; Rosner, G.; Allen, S. L.; Costanza, M.; Van Echo, D. A.; Henderson, I. C.; Schilsky, R. L. J. Clin. Oncol. 1995, 13, 741. doi: 10.1200/JCO.1995.13.3.741

  3. [3]

     Ratain, M. J.; Mick, R.; Berezin, F.; Janisch, L.; Schilsky, R. L.; Williams, S. F.; Smiddy, J. Clin. Pharmacol. Ther. 1991, 50, 573. doi: 10.1038/clpt.1991.183

  4. [4]

     Kokosza, K.; Andrei, G.; Schols, D.; Snoeck, R.; Piotrowska, D. G. Bioorg. Med. Chem 2015, 23, 3135. doi: 10.1016/j.bmc.2015.04.079

  5. [5]

     Quintana-Espinoza, P.; Martin-Acosta, P.; Amesty, A.; Martin-Rodriguez, P.; Lorenzo-Castrillejo, I.; Fernandez-Perez, L.; Machin, F.; Estevez-Braun, A. Bioorg. Med. Chem. 2017, 25, 1976. doi: 10.1016/j.bmc.2017.02.024

  6. [6]

     Verma, M.; Luxami, V.; Paul, K. RSC Adv. 2015, 5, 41803. doi: 10.1039/C5RA00925A

  7. [7]

     Rong, R.-X.; Sun, Q.; Ma, C.-L.; Chen, B.; Wang, W.-Y.; Wang, Z. A.; Wang, K. R.; Cao, Z. R.; Li, X. L. Med. Chem. Commun. 2016, 7, 679. doi: 10.1039/C5MD00543D

  8. [8]

     Tian, Z.; Huang, Y.; Zhang, Y.; Song, L.; Qiao, Y.; Xu, X.; Wang, C. J. Photochem. Photobiol. B Biol. 2016, 158, 1. doi: 10.1016/j.jphotobiol.2016.01.017

  9. [9]

     Li, F.; Cui, J.; Guo, L.; Qian, X.; Ren, W.; Wang, K.; Liu, F. Bioorg. Med. Chem.2007, 15, 5114. doi: 10.1016/j.bmc.2007.05.032

  10. [10]

      Qian, X.; Li, Y.; Xu, Y.; Liu, Y.; Qu, B. Bioorg. Med. Chem. Lett. 2004, 14, 2665. doi: 10.1016/j.bmcl.2004.02.059

  11. [11]

      Brana, M. F.; Cacho, M.; Garcia, M. A.; de Pascual-Teresa, B.; Ramos, A.; Dominguez, M. T.; Pozuelo, J. M.; Abradelo, C.; Rey-Stolle, M. F.; Yuste, M.; et al. J. Med. Chem. 2004, 47, 1391. doi: 10.1021/jm0308850

  12. [12]

      Hsiang, Y. H.; Liu, L. F. Cancer Res. 1988, 48, 1722.

  13. [13]

      Hurley, L. H.; Boyd, F. L. Trends Pharmacol. Sci. 1988, 9, 402. doi: 10.1016/0165-6147(88)90067-3

  14. [14]

      Johnson, C. A.; Hudson, G. A.; Hardebeck, L. K. E.; Jolley, E. A.; Ren, Y.; Lewis, M.; Znosko, B. M. Bioorg. Med. Chem. 2015, 23, 3586. doi: 10.1016/j.bmc.2015.04.030

  15. [15]

      Tan, S.; Sun, D.; Lyu, J.; Sun, X.; Wu, F.; Li, Q.; Yang, Y.; Liu, J.; Wang, X.; Chen, Z.; et al. Bioorg. Med. Chem. 2015, 23, 5672. doi: 10.1016/j.bmc.2015.07.011

  16. [16]

      Sun, Y.; Li, J.; Zhao, H.; Tan, L. J. Inorg. Biochem. 2016, 163, 88. doi: 10.1016/j.jinorgbio.2016.04.028

  17. [17]

      赵顺省, 李兰兰, 刘向荣, 丁作成, 杨再文.物理化学学报, 2017, 33, 356. doi: 10.3866/ PKU.WHXB201610191Zhao, S. S.; Li, L. L.; Liu, X. R.; Ding, Z. C.; Yang, Z. W. Acta Phys. -Chim. Sin. 2017, 33, 356. doi: 10.3866/PKU.WHXB201610191

  18. [18]

      Mijatovic, T.; Mahieu, T.; Bruyere, C.; De Neve, N.; Dewelle, J.; Simon, G.; Dehoux, M. J. M.; van der Aar, E.; Haibe-Kains, B.; Bontempi, G.; et al. Neoplasia 2008, 10, 573. doi: 10.1593/neo.08290

  19. [19]

      Ji, L.; Yang, S.; Li, S.; Liu, S.; Tang, S.; Liu, Z.; Meng, X.; Yu, S. Oncotarget 2017, 8, 37394. doi: 10.18632/oncotarget.16962

  20. [20]

      Paeschkel, K.; Simonsson, T.; Postberg, J.; Rhodes, D.; Lipps, H. J. Nat. Struct. Mol. Biol. 2005, 12, 847. doi: 10.1038/nsmb982

  21. [21]

      Siddiqui-Jain, A.; Grand, C. L.; Bearss, D. J.; Hurley, L. H. Proc. Nat. Acad. Sci. USA 2002, 99, 11593. doi: 10.1073/pnas.182256799

  22. [22]

      Zhang, J.; Yu, Q.; Li, Q.; Yang, L.; Chen, L.; Zhou, Y.; Liu, J. J. Inorg. Biochem. 2014, 134, 1. doi: 10.1016/j.jinorgbio.2013.12.005

  23. [23]

      Mulholland, K.; Wu, C. J. Chem. Inf. Model. 2016, 56, 2093. doi: 10.1021/acs.jcim.6b00473

  24. [24]

      Drygin, D.; Siddiqui-Jain, A.; O'Brien, S.; Schwaebe, M.; Lin, A.; Bliesath, J.; Ho, C. B.; Proffitt, C.; Trent, K.; Whitten, J. P.; et al. Cancer Res. 2009, 69, 7653. doi: 10.1158/0008-5472.CAN-09-1304

  25. [25]

      王雅芬, 张雄, 刘朝兴, 周翔.化学学报, 2017, 75, 692. doi: 10.6023/A17040162Wang, Y. F.; Zhang, X.; Liu, C. X.; Zhou, X. Acta Chim. Sin. 2017, 75, 692. doi: 10.6023/A17040162

  26. [26]

      Ou, T.; Lu, Y.; Tan, J.; Huang, Z.; Wong, K.; Gu, L. ChemMedChem 2008, 3, 690. doi: 10.1002/cmdc.200700300

  27. [27]

      Neidle, S. J. Med. Chem. 2016, 59, 5987. doi: 10.1021/acs.jmedchem.5b0183

  28. [28]

      郑小辉, 穆舸, 谭彩萍, 曹乾, 毛宗万.中国科学:化学, 2014, 44, 484. doi: 10.1360/032013-340Zheng, X.; Mu, K.; Tan, C.; Cao, Q.; Mao, Z. Sci. China Chem. 2014, 44, 484. doi: 10.1360/032013-340

  29. [29]

      Sissi, C.; Lucatello, L.; Krapcho, A. P.; Maloney, D. J.; Boxer, M. B.; Camarasa, M. V.; Pezzoni, G.; Menta, E.; Palumbo, M. Bioorg. Med. Chem. 2007, 15, 555. doi: 10.1016/j.bmc.2006.09.029

  30. [30]

      Peduto, A.; Pagano, B.; Petronzi, C.; Massa, A.; Esposito, V.; Virgilio, A.; Paduano, F.; Trapasso, F.; Fiorito, F.; Florio, S.; et al. Bioorg. Med. Chem. 2011, 19, 6419. doi: 10.1016/j.bmc.2011.08.062

  31. [31]

      Ou, Z.; Qian, Y.; Gao, Y.; Wang, Y.; Yang, G.; Li, Y.; Jiang, K.; Wang, X. RSC Adv. 2016, 6, 36923. doi: 10.1039/c6ra01441k

  32. [32]

      Ou, Z.; Xu, M.; Gao, Y.; Hu, R.; Li, Q.; Cai, W.; Wang, Z.; Qian, Y.; Yang, G. New J. Chem. 2017, 41, 9397. doi: 10.1039/c7nj02366a

  33. [33]

      Sur, S.; Tiwari, V.; Sinha, D.; Kamran, M. Z.; Dubey, K. D.; Kumar, G. S.; Tandon, V. ACS Omega 2017, 2, 966. doi: 10.1021/acsomega.6b00523

  34. [34]

      Mancini, J.; Rousseau, P.; Castor, K. J.; Sleiman, H. F.; Autexier, C. Biochimie 2016, 121, 287. doi: 10.1016/j.biochi.2015.12.015

  35. [35]

      Hu, M. H.; Chen, S. B.; Wang, B.; Ou, T. M.; Gu, L. Q.; Tan, J. H.; Huang, Z. S. Nucleic Acids Res. 2017, 45, 1606. doi: 10.1093/nar/gkw1195

  36. [36]

      Huang, J.; Li, G.; Wu, Z.; Song, Z.; Zhou, Y.; Shuai, L.; Weng, X.; Zhou, X.; Yang, G. Chem. Commun. 2009, 8, 902. doi: 10.1039/b819789j

  37. [37]

      Czirok, J. B.; Bojtar, M.; Hessz, D.; Baranyai, P.; Drahos, L.; Kubinyi, M.; Bittera, I. Sensor Actuat B-Chem. 2013, 182, 280. doi: 10.1016/j.snb.2013.02.046

  38. [38]

      Wang, D.; Zhang, X.; He, C.; Duan, C. Org. Biomol. Chem. 2010, 8, 2923. doi: 10.1039/C004148C

  39. [39]

      Kim, H. N.; Lee, E. H.; Xu, Z.; Kim, H. E.; Lee, H. S.; Lee, J. H.; Yoon, J. Biomaterial 2012, 33, 2282. doi: 10.1016/j.biomaterials.2011.11.073

  40. [40]

      Street, S.; Chin, D.; Hollingworth, G.; Berry, M.; Morales, J. C.; Galan, M. C. Chem. Eur. J. 2017, 23, 6953. doi: 10.1002/chem.201700140

  41. [41]

      Chen, J. S.; Zhou, P. W.; Li, G. Y.; Chu, T. S.; He, G. Z. J. Phys. Chem. B, 2013, 117, 5212. doi: 10.1021/jp4017757

  42. [42]

      Romanucci, V.; Marchand, A.; Mendoza, O.; D'Alonzo, D.; Zarrelli, A.; Gabelica, V.; Fabio, G. D. ACS Med. Chem. Lett. 2016, 7, 256. doi: 10.1021/acsmedchemlett.5b00408

  43. [43]

      Fleming, A. M.; Ding, Y.; Alenko, A.; Burrows, C. J. ACS Infect. Dis. 2016, 2, 674. doi: 10.1021/acsinfecdis.6b00109

  44. [44]

      Xu, X. L.; Wang, J.; Yu, C. L.; Chen, W.; Li, Y. C.; Li, Y.; Zhang, H. B.; Yang, X. D. Bioorg. Med. Chem. Lett. 2014, 24, 4926. doi: 10.1016/j.bmcl.2014.09.045

  45. [45]

      Elshaarawy, R. F. M.; Kheiralla, Z. H.; Rushdy, A. A.; Janiak, C. Inorg. Chim. Acta 2014, 421, 110. doi: 10.1016/j.ica.2014.05.029

  46. [46]

      Ranke, J.; Cox, M.; Muller, A.; Schmidt, C.; Beyersmann, D. Toxicol. Environ. Chem. 2006, 88, 273. doi: 10.1080/02772240600589505

  47. [47]

      罗晓燕, 钱鹰.有机化学, 2013, 33, 2423. doi: 10.6023/cjoc201305034Luo, X.; Qian, Y. Chin. J. Org. Chem. 2013, 33, 2423. doi: 10.6023/cjoc201305034

  48. [48]

      Manojkumar, K.; Charan, K. T. P.; Sivaramakrishna, A.; Jha, P. C.; Khedkar, V. M.; Siva, R.; Jayaraman, G.; Vijayakrishna, K. Biomacromolecules 2015, 16, 894. doi: 10.1021/bm5018029

  49. [49]

      Rao, L.; Dworkin, J. D.; Nell, W. E.; Bierbach, U. J. Phys. Chem. B 2011, 115, 13701. doi: 10.1021/jp207265s

  50. [50]

      Georgiades, S. N.; Karim, N. H. A.; Suntharalingam, K.; Vilar, R. Angew. Chem. Int. Ed. 2010, 49, 4020. doi: 10.1002/anie.200906363

  51. [51]

      Raju, G.; Vishwanath, S.; Prasad, A.; Patel, B. K.; Prabusankar, G. J. Mol. Struct. 2016, 1107, 291. doi: 10.1016/j.molstruc.2015.11.064

  52. [52]

      Zhou, J.; Chang, A.; Wang, L.; Liu, Y.; Liu, X.; Shangguan, D. Org. Biomol. Chem. 2014, 12, 9207. doi: 10.1039/C4OB01274G

  53. [53]

      Wang, K. R.; Qian, F.; Sun, Q.; Ma, C. L.; Rong, R. X.; Cao, Z. R., Wang, X. M.; Li, X. L. Chem. Biol. Drug Des. 2016, 87, 664. doi: 10.1111/cbdd.12698

  54. [54]

      欧植泽, 句宝龙, 高云燕, 王子超, 黄干, 钱一梦.物理化学学报, 2015, 31, 2386. doi: 10.3866/PKU.WHXB201510l3Ou, Z. Z.; Ju, B. L.; Gao, Y. Y.; Wang, Z. C.; Huang, G.; Qian, Y. M. Acta Phys. -Chim. Sin. 2015, 31, 2386. doi: 10.3866/PKU.WHXB201510l3

  55. [55]

      Loganathan, R.; Ramakrishnan, S.; Suresh, E.; Riyasdeen, A.; Akbarsha, M. A.; Palaniandavar, M. Inorg. Chem. 2012, 51, 5512. doi: 10.1021/ic2017177

  56. [56]

      Barton, J. K.; Goldberg, J. M.; Kumar, C. V.; Turro, N. J. J. Am. Chem. Soc. 1986, 108, 2081. doi: 10.1021/ja00268a057

  57. [57]

      Satyanarayana, S.; Dabrowiak, J. C.; Chaires, J. B. Biochemistry 1993, 32, 2573. doi: 10.1021/bi00061a015

  58. [58]

      Ou, Z.; Wang, Y.; Gao, Y.; Wang, X.; Qian, Y.; Li, Y.; Wang, X. J. Inorg. Biochem. 2017, 166, 126. doi: 10.1016/j.jinorgbio.2016.11.012

  59. [59]

      Sun, D.; Liu, Y.; Yu, Q.; Liu, D.; Zhou, Y.; Liu, J. J. Inorg. Biochem. 2015, 150, 90. doi: 10.1016/j.jinorgbio.2015.04.003

  60. [60]

      Xu, X.; Wang, X.; Li, Y.; Wang, Y.; Yang, L. Nucleic Acids Res. 2012, 40, 7622. doi: 10.1093/nar/gks517

  61. [61]

      Chenoweth, D. M.; Dervan, P. B. Proc. Nat. Acad. Sci. USA 2009, 106, 13175. doi: 10.1073/pnas.0906532106

  62. [62]

      Ghosh, S.; Mendoza, O.; Cubo, L.; Rosu, F.; Gabelica, V.; White, A. J. P.; Vilar, R. Chem. Eur. J. 2014, 20, 4772. doi: 10.1002/chem.201304905

•